BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Eccogene Raises CNY 180M in Series B Financing for Metabolic Disease Treatments

Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...

June 12, 2023 | News

China Approves World's First Vaccine for XBB Descendent Lineages of SARS-CoV-2

WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...

June 12, 2023 | News

Dizal Highlights Oncology Pipeline Strength at 2023 ASCO, Leading China's Biotech Innovation

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidoci...

June 08, 2023 | News

EVERSANA Allies with China Resource Pharmaceutical for Global Novel Treatments

Together, the two organizations will collaborate on helping expand access to innovative healthcare solutions that are available both in and outside of ...

June 02, 2023 | News

WuXi Biologics to Increase Manufacturing Capacity in Germany

- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...

June 02, 2023 | News

Innovent Collaborates with Merck KGaA to Study Combination Therapy for KRASG12C-mutated NSCLC in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 02, 2023 | News

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

Dr. Nie Junwei, General Manager of Life Science Division, Vazyme, and Mr. George Ge, General Manager of Azenta China, witnessed by Dr. Cao Lin, C...

June 01, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Luzhu Biotechnology's LZ901 Completes Phase II Clinical Trial for Herpes Zoster Vaccine

Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a l...

May 31, 2023 | News

Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers

Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...

May 24, 2023 | News

Thousand Oaks Biologics and GeneQuantum Healthcare Partner for ADC Drug Development

The over 200 million RMB collaboration will allow GQ to leverage TOBio's expertise in CMC and commercial manufacturing to advance its pharmaceutica...

May 23, 2023 | News

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...

May 23, 2023 | News

GenScript boosts peptide and synthetic RNA production in China

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its primary manufacturing facility fo...

May 19, 2023 | News

HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics

HitGen will utilize its DNA-encoded library (DEL) technology platform, centered around the design, synthesis and screening of DELs, to identify novel inhib...

May 19, 2023 | News

Stay Connected